Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

The DEER database: a bridge connecting drugs, environmental effects, and regulations.

Yu Q, Huang JF.

Gene. 2013 May 15;520(2):98-105. doi: 10.1016/j.gene.2013.03.005. Epub 2013 Mar 13.

PMID:
23500449
2.

Pharmacogenetics, pharmacogenomics, and individualized medicine.

Ma Q, Lu AY.

Pharmacol Rev. 2011 Jun;63(2):437-59. doi: 10.1124/pr.110.003533. Epub 2011 Mar 24. Review.

3.

Pharmacogenetics and personalised medicine.

Kalow W.

Fundam Clin Pharmacol. 2002 Oct;16(5):337-42. Review.

PMID:
12602458
4.

Genetic polymorphism and toxicology--with emphasis on cytochrome p450.

Johansson I, Ingelman-Sundberg M.

Toxicol Sci. 2011 Mar;120(1):1-13. doi: 10.1093/toxsci/kfq374. Epub 2010 Dec 13. Review.

PMID:
21149643
5.

Pharmacogenetics-based new therapeutic concepts.

Roots I, Gerloff T, Meisel C, Kirchheiner J, Goldammer M, Kaiser R, Laschinski G, Brockmöller J, Cascorbi I, Kleeberg U, Hildebrandt AG.

Drug Metab Rev. 2004 Oct;36(3-4):617-38. Review.

PMID:
15554239
6.

Polymorphism of human cytochrome P450 enzymes and its clinical impact.

Zhou SF, Liu JP, Chowbay B.

Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Review.

PMID:
19514967
7.

Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.

Rushmore TH, Kong AN.

Curr Drug Metab. 2002 Oct;3(5):481-90. Review.

PMID:
12369894
8.

How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).

Preskorn SH, Hatt CR.

J Psychiatr Pract. 2013 Mar;19(2):142-9. doi: 10.1097/01.pra.0000428559.01953.73. Review.

PMID:
23507814
9.

[Therapeutic implications of polymorphisms in cytochromes and drug transporters].

Münster E, Ziegler S, Brunner M.

Wien Med Wochenschr. 2005 Feb;155(3-4):54-8. German.

PMID:
15791777
10.

Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.

Johnson AD, Wang D, Sadee W.

Pharmacol Ther. 2005 Apr;106(1):19-38. Epub 2004 Dec 15. Review.

PMID:
15781120
11.

Genetic factors in drug metabolism.

Belle DJ, Singh H.

Am Fam Physician. 2008 Jun 1;77(11):1553-60. Review.

12.

Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.

Pilotto A, Panza F, Seripa D.

Curr Drug Metab. 2011 Sep;12(7):621-34. Review.

PMID:
21495974
13.

Pharmacogenetics and the concept of individualized medicine.

Shastry BS.

Pharmacogenomics J. 2006 Jan-Feb;6(1):16-21. Review.

PMID:
16302022
14.

Pharmacogenetics of the cytochromes P450.

Daly AK.

Curr Top Med Chem. 2004;4(16):1733-44. Review.

PMID:
15579105
15.
16.

Genotyping as a tool to predict adverse drug reactions.

Güzey C, Spigset O.

Curr Top Med Chem. 2004;4(13):1411-21. Review.

PMID:
15379654
17.

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

Ingelman-Sundberg M.

Trends Pharmacol Sci. 2004 Apr;25(4):193-200. Review.

PMID:
15063083
18.

Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.

Lamba J, Lamba V, Schuetz E.

Curr Drug Metab. 2005 Aug;6(4):369-83. Review.

PMID:
16101575
19.

Comparative and veterinary pharmacogenomics.

Mosher CM, Court MH.

Handb Exp Pharmacol. 2010;(199):49-77. doi: 10.1007/978-3-642-10324-7_3. Review.

PMID:
20204583
20.

[Pharmacogenomics: the quest for individualized therapy].

López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME.

Rev Neurol. 2004 Dec 1-15;39(11):1063-71. Review. Spanish.

Supplemental Content

Support Center